Skip to main content
KANABO GROUP PLC logo

KANABO GROUP PLC — Investor Relations & Filings

Ticker · KNB ISIN · GB00BYQCS703 LEI · 213800XPJFSNWJIYKN52 IL Manufacturing
Open in API
Filings indexed 247 across all filing types
Latest filing 2023-07-20 Regulatory Filings
Country GB United Kingdom
Listing IL KNB

About KANABO GROUP PLC

https://www.kanabogroup.com/

Kanabo Group PLC is a digital health company focused on the research, development, and commercialization of cannabis-derived products. The company distributes cannabis-derived formulations for medical patients and non-THC products for CBD consumers. Its research and development efforts create proprietary, patent-pending formulas for conditions such as sleep and central nervous system (CNS) disorders. A key component of its offering is the VapePod®, a medically certified vaporization device that enables precise, metered-dosing of cannabis extracts. The company also operates The GP Service, a telehealth platform providing digital health services, including video consultations and online prescriptions, which integrates primary care with its specialist medicine offerings.

Recent filings

Filing Released Lang Actions
Group of companies' accounts made up to 2022-12-31
Regulatory Filings
2023-07-20 English
Success for Kanabo Agritec with Contract Award
Regulatory Filings Classification · 100% confidence The document begins with 'RNS Number : 1462G' and is dated 17 July 2023. It details a commercial contract award for Kanabo Agritec regarding a medical cannabis facility in Spain. The text concludes with standard boilerplate language referencing RNS, the London Stock Exchange, and the Financial Conduct Authority (FCA). This structure is characteristic of a general regulatory news service announcement, which is not covered by the more specific categories like ER, 10-K, or DIV. Since it is a general announcement disseminated via the RNS system that doesn't fit precisely into the other defined categories (like M&A, Capital Change, or Director Dealing), the most appropriate fallback category is Regulatory Filings (RNS). The document length (6899 chars) is substantial enough that it is not merely an announcement *about* a report, but the report itself, though it is a news announcement rather than a formal statutory filing like a 10-K.
2023-07-17 English
Issue of New Ordinary Shares and TVR
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content announces the 'Issuance of New Ordinary Shares' and provides the 'Total Voting Rights' figure (611,677,871 shares), which is a mandatory disclosure related to capital structure changes and shareholder notification thresholds (FCA Disclosure Guidance and Transparency Rules). This type of announcement, which details a change in the number of shares in issue and the resulting total voting rights, fits best under 'Share Issue/Capital Change' (SHA). Although it is distributed via RNS, the core subject matter is a capital change, making SHA more specific than the general fallback RNS.
2023-07-10 English
Result of AGM
AGM Information Classification · 100% confidence The document explicitly states it is announcing the "Result of AGM" (Annual General Meeting). It details the outcome of thirteen resolutions voted upon during the AGM, presenting the 'Total For', 'Total Against', and 'Withheld' votes in a table format. This content directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, specifically the results of voting.
2023-06-30 English
Issue of New Ordinary Shares and TVR
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details the 'Issuance of New Ordinary Shares and Total Voting Rights' following a prospectus completion and subsequent admission to the London Stock Exchange. This announcement relates to a change in the total number of shares in issue, which directly impacts capital structure and shareholder voting rights denominator. While it touches upon capital changes (SHA) and voting rights (DVA), the core regulatory function here is a mandatory notification about the total voting rights count (573,216,379 shares) required by the FCA's Disclosure Guidance and Transparency Rules. This type of general regulatory update that doesn't fit perfectly into the specific categories like 10-K, ER, or DIV is best classified as a general Regulatory Filing (RNS), as it is a standard market disclosure via the RNS system.
2023-06-28 English
Grant of Options
Director's Dealing Classification · 99% confidence The document is identified by the header 'RNS Number : 6602D' and explicitly mentions 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details the 'Grant of Options' to employees and Persons Discharging Managerial Responsibilities (PDMRs), including specific transaction tables required for insider dealing/management transactions disclosure under MAR regulations. While it contains details about management transactions (which could sometimes fall under DIRS), the primary nature of this announcement, being disseminated via the RNS system of the LSE, strongly suggests it is a general regulatory announcement. Since the specific category 'Director's Dealing (DIRS)' is for reporting personal share transactions, and this document reports the *granting* of options to management (a mandatory disclosure often filed through RNS), the most appropriate general regulatory filing category that captures this type of mandatory market disclosure, especially when it doesn't fit perfectly into the other specific categories like DIV, CAP, or DIRS (which usually focuses on buying/selling existing shares, not option grants), is the general regulatory filing category, RNS. However, upon reviewing the definitions, 'Director's Dealing (DIRS)' is defined as 'Report of personal share transactions by company directors and executives (insider trades).' Granting options to PDMRs is a form of insider transaction disclosure. Given the detailed tables showing transactions by named directors/executives (David Tsur, Ian Mattioli, Assaf Vardimon, etc.) regarding share options, DIRS is a stronger fit than the general RNS fallback, as it specifically covers executive transactions/dealings, even if they are option grants rather than open-market purchases. The presence of the MAR notification structure confirms this is an insider transaction report.
2023-06-23 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.